Diabetes Mellitus Induced by Exogenous Administration of Glucocorticoids

Main Article Content

L.A. Nykytiuk


The questions of the diagnosis and treatment of steroid-induced diabetes mellitus are considered in the lecture.

Article Details

How to Cite
Nykytiuk, L. “Diabetes Mellitus Induced by Exogenous Administration of Glucocorticoids”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), no. 8.80, Jan. 2017, pp. 17-19, doi:10.22141/2224-0721.8.80.2016.89532.


Trigolosova IV. Steroid induced diabetes mellitus. RMJ. 2016;1:54-56 (Russian)

Fardet L, Peterson I, Nazareth I. Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years. Rheumatology. 2011;50(11):1982-1990.

Gulliford MC, Charlton J, Latinovic R. Risk of diabetes associated with prescribed glucocorticoids in a large population. Diabetes Care. 2006;29:2728–2729.

Papang R, John AS, Abraham S, Rao PS. A study of steroid-induced diabetes mellitus in leprosy. Indian J Lepr. 2009;81:125-129.

Donihi AC, Raval D, Saul M. еt al. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract. 2006;12:358-362.

White BD, Dean RG, Edwards GL. et al. Type II corticosteroid receptor stimulation increases NPY gene expression in basomedial hypothalamus of rats. Am. J. Physiol. 1994;266(5 Pt 2):1523-9.

Raalte DH van, Nofrate V, Bunck MC. et al. Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men. Eur J Endocrinol. 2010;162:729-735.

Hansen KB, Vilsbøll T, Bagger JI. et al. Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects. Journal of Clinical Endocrinology and Metabolism. 2010;95(7):3309-3317.

Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2013;37(1):1–212.

Management of Hyperglycaemia and Steroid (Glucocorticoid) Therapy. JBDS. October 2014. www.diabetologists-abcd.org.uk/JBDS/JBDS.htm.

Zheng D, Ionut V, Mooradian V. et. al. Exenatide sensitizes insulin-mediated whole-body glucose disposal and promotes uptake of exogenous glucose by the liver. Diabetes. 2009;58:352–359.

Van Raalte DH, Van Genugten RE, Linssen MM. et al. Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans. Diabetes Care. 2011;34:412-417.